Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Extrapancreatic Neuroendocrine Tumor × Tegafur × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Extrapancreatic Neuroendocrine Tumor 1 Advanced Pancreatic Cancer 1 Adenoma, Islet Cell 1

Interventions

Thalidomide 1 Temozolomide 1 Tegafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

ChineseAMS

Phase 2 Unknown

EndocrineGastrointestinalNET

Extrapancreatic Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡